Impact on change in serum beta 2 microglobulin by combination therapy of peritoneal dialysis and hemodialysis: a 12-month preliminary observational study

Impact on change in serum beta 2 microglobulin by combination therapy of peritoneal dialysis and hemodialysis: a 12-month preliminary observational study

Abstract Background In the Japanese guidelines on combination peritoneal dialysis (PD) and hemodialysis (HD) therapy, patients with serum beta 2 microglobulin (β2MG) levels less than 30 mg/L are recommended. And PD patients with β2MG more than 30 mg/L are considered to transfer to the PD + HD combin...

Full description

Bibliographic Details
Main Authors: Shinobu Moriya, Shun Nishizawa, Yayoi Tsuchihashi, Yoshihiro Inoue, Kimio Watanabe, Yugo Ito, Hassu Kin, Masaaki Nakayama
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Renal Replacement Therapy
Subjects:
Serum beta2 microglobulin
Peritoneal dialysis
Hemodialysis
Combination therapy
Online Access:https://doi.org/10.1186/s41100-022-00447-y

Internet

https://doi.org/10.1186/s41100-022-00447-y

Similar Items